The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

The pharmacy benefit managers, which were named in two of the complaints—CVS Caremark, Express Scripts, MedImpact, and ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

Walgreens Boots Alliance has a storied history in Chicago, starting with a single retail outlet in 1901, and expanding across ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

Express Scripts said the legal action was "reckless ... chief legal officer at Cigna. CVS Caremark said that preventing PBMs from negotiating drug prices will only benefit pharma companies ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Those companies are: * Caremark Rx, which is owned by CVS Health. * Express Scripts which is subsidiary of Cigna. * OptumRx, which is owned by UnitedHealth. Angela Mattie, a professor of ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...